Advertisement
Screener

PHARMACYTE BIOTECH, INC. (PMCB) Preferred Stock, Shares Outstanding

2.8 / 5 stars · 68/120 Roast Me

PHARMACYTE BIOTECH, INC. Preferred Stock, Shares Outstanding

PHARMACYTE BIOTECH, INC. (PMCB) had Preferred Stock, Shares Outstanding of 35.00 thousand shares as of 2023-07-31, per its 10-Q filed 2023-09-18.

Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesOutstanding · last filed 2023-09-18

  • 2023-07-31: Preferred Stock, Shares Outstanding 35.00K shares.
  • 2023-04-30: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2023-01-31: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2022-10-31: Preferred Stock, Shares Outstanding 0.00 shares.
Period endPreferred Stock, Shares Outstanding
2023-07-3135.00K shares
10-Q · filed 2023-09-18
2023-04-300.00 shares
10-K · filed 2023-07-31
2023-01-310.00 shares
10-Q · filed 2023-03-16
2022-10-310.00 shares
10-Q · filed 2022-12-14
2022-07-310.00 shares
10-Q · filed 2022-09-14
2022-04-300.00 shares
10-K · filed 2023-07-31
2022-01-310.00 shares
10-Q · filed 2022-03-15
2021-04-300.00 shares
10-K · filed 2021-08-10
2020-01-310.00 shares
10-Q · filed 2020-03-13
2019-04-300.00 shares
10-Q · filed 2020-03-13
2016-01-310.00 shares
10-Q · filed 2016-03-08
2015-10-310.00 shares
10-Q/A · filed 2016-01-19
2015-07-310.00 shares
10-Q/A · filed 2016-01-19
2015-04-300.00 shares
10-Q · filed 2016-03-08
2015-01-310.00 shares
10-Q · filed 2015-03-13
2014-10-310.00 shares
10-Q · filed 2014-12-15
2014-07-310.00 shares
10-Q · filed 2014-09-15
2014-04-300.00 shares
10-K/A · filed 2016-01-19
2014-01-310.00 shares
10-Q · filed 2014-03-17
2013-10-310.00 shares
10-Q · filed 2013-12-16
2013-04-308.50K shares
10-K · filed 2014-08-04
2012-10-318.50K shares
10-Q · filed 2012-12-26
2012-04-308.50K shares
10-Q · filed 2012-12-26
2011-04-303.50K shares
10-K · filed 2013-07-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
CURIS INC (CRIS)United States$0.002B-0.05
Silexion Therapeutics Corp (SLXN)$0.001B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70